Navigation Links
Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Among Latinos
Date:10/13/2008

National Latino AIDS Awareness Day Encourages Latinos to Get Tested

LOS ANGELES, Oct. 13 /PRNewswire/ --

WHAT

-- Latinos make up almost half of all newly diagnosed HIV/AIDS cases reported in Los Angeles County compared to 19 percent nationally.

-- A week of activities aimed at raising awareness and encouraging HIV counseling and testing to coincide with National Latino AIDS Awareness Day observed on October 15.

-- October 14, Our Community, Our Responsibility: Latinos in Action -- Latino AIDS activists, public health officials, policy makers and other community leaders will gather to discuss strategies aimed at stemming the growing number of Latinos affected by HIV/AIDS. Discussions will focus on policy, funding and media strategies.

-- October 14-18, Free HIV Counseling and Testing -- Nearly 40 HIV testing and counseling sites throughout L.A. County will step up efforts to encourage Latinos to get tested. Recent studies show that some Latinos are testing way too late and are often infected 8 to 10 years before getting tested for HIV. It is likely many have unknowingly transmitted HIV to others during this time. Early treatment can help prevent an AIDS diagnosis and lead to a good quality of life.

WHEN & WHERE

Oct. 14, 9:00 am - 4:30 pm, Our Community, Our Responsibility: Latinos in Action -- media invited at 8:30 am, California Endowment, Redwood Room, 1000 North Alameda Street, Los Angeles, 90012

HIV Counseling and Testing sites -- media invited by appointment

-- Oct. 16, 10 am to 4 pm, Homeboy Enterprises, 130 W. Bruno Street, Los Angeles 90012

-- Oct. 15, 10 am to 3 pm, AIDS Healthcare Foundation, MacArthur Park, 1321 E. Anaheim Street, Long Beach 90815

-- Oct. 15, 11 am to 9 pm, Altamed Health Services & Oldtimers Foundation, Shopping Center at Pacific & Florence

-- Oct. 17, 10 am to Noon, Bienestar, Donut Shop at Florence & Pacific Blvd, Huntington Park, 90255 '/>"/>

SOURCE County of Los Angeles, Department of Public Health Officeof AIDS
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
2. Nearly 30 Percent of Realtors(R) Lack Health Insurance
3. New Poll Finds Nearly Seven in 10 New Jersey Voters Support Smoke-Free Casinos
4. New Pharmaceutical Sales Force Communication Metrics: Nearly 6 Weeks of Sales Time per Rep Wasted Each Year
5. Anticancer Drugs Targeting the ErbB (EGFr/HEr2) Pathway Alone Generated Global Sales of Nearly $5 Billion in the First Nine Months of 2007
6. K-State Researchers Predict That an Outbreak of Foot-And-Mouth Disease Could Cost Kansas Nearly a Billion Dollars
7. Smokers Cost Medicaid System Nearly $10 Billion
8. Research Indicates Nearly 25 Percent of Supplements Are Contaminated With Steroids, Stimulants and Banned Substances
9. Cipla Offers Modest AIDS Drug Price Cut: Not Nearly Enough, says AHF
10. Metabolic syndrome affects nearly 1 in 10 US teens
11. Eleven Florida Nonprofit Organizations to Receive Grants Totaling Nearly $1 Million From The Blue Foundation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., DALLAS,Nov.27/PRNewswire-USNewswire/--Conside...y25yearsago,solidorgantransplantationisnowalife-sa...andwomenwhogatheredattheWinspearOperaHouseinDallas...ndtheworldtocelebratethe25thanniversaryofBaylorReg...olidorgantransplantintheUnitedStates. ,, Itwas2...
(Date:11/27/2009)... , ROCHESTER, N.Y., Nov. 27 /PRNewswire-USNe... health care provider and fortunately every year, ...prevention. But do all vaccines boost immunity for...ditional ,booster shots, needed to keep immunity s..., the Journal of the American Academy of Pediatric...
(Date:11/27/2009)... , KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswir...aq: SHMR ) ( "Shamir" ), a leading provider of in... lens market, announced today that its board of di... aggregate amount of US$ 10 million (approximately...representative rate of exchange), or approximately...
(Date:11/27/2009)...king and cycling plus low-emission vehicles may re... , FRIDAY, Nov. 27 (HealthDay News) -- Encour... using cars would offer much greater public health...cles, U.K. researchers have found. , The study ...lternative urban land transport scenarios for Lond...
(Date:11/27/2009)..., SEATTLE,Nov.27/PRNewswire/-- Allrecipes.com ...vingtrafficnumbers,withmorethan2.8millionvisitorst...atwasservedonthebiggestfoodholidayoftheyear.Theave...perserving,a5percentincreasefromlastyear,sfeast.Ac...heshowasthemostpopularThanksgivingrecipe,acontrast...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3
...bivalirudin (Angiomax) that beats the standard com...nary syndromes such as heart// attacks. This new b...uffering from acute coronary syndromes. The ...nal of Medicine. The Medicines Company and Nycome...
... in a Farm in South Korea, killing around 6,000 ch... more, South Korea’s Farm// Ministry officials sai...ference, Kim Chang-sub, a top official at the Mini...s of our testing should be known on 25th of Novemb...
...e sale of turbot after they detected high levels o...ing’s fish markets, reports the Chinese media. The...pe in 1992. Due to low resistance to disease...n, Liaoning and Xi'an have started inspections aft...
...s grouped the five major cities Vancouver//, Calga...ods, based on five features namely income, educa...one-parent families. It also observes neighb...streets, public transportation, and how well peopl...
...ert with sophisticated transgenic technologies, //...rst time created three-dimensional, time-lapse mov... live tumor tissues. In recorded experiments, immu...his new view of the body’s on-board defenses again...
... had to be hospitalized following cosmetic injecti...an cosmetic product that was unlicensed. The injec...es greater than the lethal dose for humans, report...ogists. Four persons including a doctor had to ...
Other Medicine News:Health News:New Anti-Clotting Drug Less Risky For Heart Attack Patients 2Health News:Health Of Residents Is Affected by Various Factors 2Health News:Innovative Movies Show Real-Time Immune-Cell Activity within Tumors 2Health News:Innovative Movies Show Real-Time Immune-Cell Activity within Tumors 3
(Date:11/27/2009)...TON, Minn, Nov. 27 ACUO TECHNOLOGI...anagement software, data migration tools and servi... Patent and Trademark Office has approved a patent...thin a Computer Network." Acuo Technologies is ple...tellectual property. In general, the granted paten...
(Date:11/25/2009)...A PARK, Calif., Nov. 25 Praxis Ele...ngs in the American Academy of Family Physicians, ...ser Satisfaction Survey for improving medical qual...ll critical for new ARRA Stimulus legislation. Pra...EMR had a positive effect in determining their sal...
(Date:11/25/2009)...ORD, Mass., Nov. 25 Holo...), a leading developer, manufacturer and supplier ...d surgical products dedicated to serving the healt...of the Radiological Society of North America (RSNA...gh December 3, 2009 to highlight our new SecurView...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Drug Combo May Offer Best Relief for Nerve Pain 58527 1Drug Combo May Offer Best Relief for Nerve Pain 58527 2Australian study sheds light on kidney repair and disease 10181 1Australian study sheds light on kidney repair and disease 10181 2Cardinal Health Foundation Invites Health Care Providers to Apply for 241 Million in Grants to Improve Efficiency Quality of Care 58524 1Cardinal Health Foundation Invites Health Care Providers to Apply for 241 Million in Grants to Improve Efficiency Quality of Care 58524 2
...ee large PEGINTRON(TM) clinical studies address ke...OPENHAGEN, Denmark, April 27 Schering-Plough Corp...esults of three large PEGINTRON(TM) (peginterferon...estions in the hepatitis C research community and ...udies, involving a total of more than 2,700 patien...
...s $10 million milestone payment to Pharmasset , ,...aq: VRUS ) and Roche (Roche SWX: RO, ROG; Pink S...nt has been dosed in a Phase IIb study of R7128, t...n development for the treatment of chronic hepatit...uration of treatment of R7128 in combination with ...
Other Medicine Technology:Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 2Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 3Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 4Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 5Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 6Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 7Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 8Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 9Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 10Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 11Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 2Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 3Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 4Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 5Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 6Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 7Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 8Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 9Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 10
ENDOlap™ 25 liter Heated Insufflator
Insufflators
KLEPPINGER bipolar forceps
...thologist to visualize the presence of Human Papil... choice of sample types: tissue, monolayer-based p...ocktails utilize proprietary probe formulations. T... genotypes 16, 18, 31, 33, 35, 39, 51, 52, 56, 58,...
Medicine Products: